CLEAR + BRILLIANT LASER SYSTEM CB-HP-1927

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2020-02-12 for CLEAR + BRILLIANT LASER SYSTEM CB-HP-1927 manufactured by Solta Medical Inc..

Event Text Entries

[185891872] Product will not be returned for evaluation because the clear+brilliant treatment tips do not deliver any energy and no treatment data is stored on the tip itself; there is no information to gather from their return. System has software safeguards that will trigger error/event codes should the system be outside of acceptable limits. Customer can also utilize the burn paper to confirm system laser is providing correct pattern/coverage. Customer did not perform requested burn paper test and thus we cannot verify proper pattern/coverage. A review of the device history record is in progress. Based on all available information, no causal factors can be determined and no conclusion can be drawn.
Patient Sequence No: 1, Text Type: N, H10


[185891873] A physician reported that three days after undergoing a clear + brilliant treatment the patient called to report they were experiencing redness and irritation across the chest, neck, and lower face, as well as throat swelling. The patient reported they initially observed redness, puffiness, and hives in the treatment area that progressively got worse. The patient self treated with benadryl. The patient visited the emergency room on the third day and the physician indicated an anaphylactic reaction had occurred and administered the patient an oral steroid and gave the patient an epi-pen in case of additional reaction. The physician believes that the patient experienced an allergic reaction to the topical gel applied to the patient. The patient is recovered. The patient was treated with clear + brilliant across the face and neck. No issues or errors were reported during the treatment. The patient was administered a topical anesthetic prior to treatment composed of lidocaine and tetracaine hcl liposav. The doctor reported that during treatment the highest power level used was high. The doctor noted following the treatment the patient was administered over the counter topical creams skinceuticals ce ferulic and colorscience even up spf 50 on the treatment site. It was reported that the patient has a sulfa allergy. The doctor also indicated that the patient underwent an ipl treatment for rosacea in the same area around 2 weeks prior to the clear + brilliant treatment.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3011423170-2020-00024
MDR Report Key9699801
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2020-02-12
Date of Report2020-02-03
Date of Event2020-01-31
Report Date2005-01-01
Date Reported to FDA2005-01-01
Date Reported to Mfgr2005-01-10
Date Mfgr Received2020-02-03
Date Added to Maude2020-02-12
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. JENNIFER GAMET
Manufacturer Street1400 N GOODMAN ST
Manufacturer CityROCHESTER NY 14609
Manufacturer CountryUS
Manufacturer Postal14609
Manufacturer Phone5853386853
Manufacturer G1SOLTA MEDICAL
Manufacturer Street11720 N CREEK PARKWAY N STE 100
Manufacturer CityBOTHELL WA 98011
Manufacturer CountryUS
Manufacturer Postal Code98011
Single Use0
Previous Use Code0
Event Type3
Type of Report3

Device Sequence Number: 1

Brand NameCLEAR + BRILLIANT LASER SYSTEM
Generic NamePOWERED LASER SURGICAL INSTRUMENT WITH MICROBEAM
Product CodeONG
Date Received2020-02-12
Model NumberCB-HP-1927
Device Availability*
Device Sequence No1
Device Event Key0
ManufacturerSOLTA MEDICAL INC.
Manufacturer Address11720 NORTH CREEK PKWY N SUITE 100 BOTHELL WA 98011 US 98011

Device Sequence Number: 101

Product Code---
Date Received2020-02-12
Device Sequence No101
Device Event Key0


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-02-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.